메뉴 건너뛰기




Volumn 124, Issue 4, 2009, Pages 397-402

Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians

Author keywords

Acute phase; Asian Indians; Coagulation Inhibitors; Factor V HR2 Haplotype; Factor V Leiden mutation; Factor VIII levels

Indexed keywords

BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; IMMUNOGLOBULIN G; PROTEIN C; PROTEIN S;

EID: 69249215228     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.02.015     Document Type: Article
Times cited : (15)

References (23)
  • 1
    • 0033667435 scopus 로고    scopus 로고
    • Diagnostic testing for coagulopathies in patients with ischemic stroke
    • Bushnell C.D., and Goldstein L.B. Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31 (2000) 3067-3078
    • (2000) Stroke , vol.31 , pp. 3067-3078
    • Bushnell, C.D.1    Goldstein, L.B.2
  • 2
    • 0028939318 scopus 로고
    • Characterization of the molecular defect in factor VR506Q
    • Kalafatis M., Bertina R.M., Rand M.D., and Mann K.G. Characterization of the molecular defect in factor VR506Q. J Biol Chem 270 (1995) 4053-4057
    • (1995) J Biol Chem , vol.270 , pp. 4053-4057
    • Kalafatis, M.1    Bertina, R.M.2    Rand, M.D.3    Mann, K.G.4
  • 3
    • 0029133654 scopus 로고
    • Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factorVaR506Q by activated protein C
    • Nicolaes G.A., Tans G., Thomassen M.C., Hemker H.C., Pabinger I., Varadi K., Schwarz H.P., et al. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factorVaR506Q by activated protein C. J Biol Chem 270 (1995) 21158-21166
    • (1995) J Biol Chem , vol.270 , pp. 21158-21166
    • Nicolaes, G.A.1    Tans, G.2    Thomassen, M.C.3    Hemker, H.C.4    Pabinger, I.5    Varadi, K.6    Schwarz, H.P.7
  • 4
    • 0029792536 scopus 로고    scopus 로고
    • Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation
    • Varadi K., Rosing J., Tans G., Pabinger I., Keil B., and Schwarz H.P. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation. Thromb Haemost 76 (1996) 208-214
    • (1996) Thromb Haemost , vol.76 , pp. 208-214
    • Varadi, K.1    Rosing, J.2    Tans, G.3    Pabinger, I.4    Keil, B.5    Schwarz, H.P.6
  • 5
    • 0033561431 scopus 로고    scopus 로고
    • Cleavage of Factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V
    • Thorelli E., Kaufman R.J., and Dahlback B. Cleavage of Factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V. Blood 93 (1999) 2552-2558
    • (1999) Blood , vol.93 , pp. 2552-2558
    • Thorelli, E.1    Kaufman, R.J.2    Dahlback, B.3
  • 6
    • 0028931717 scopus 로고
    • High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
    • Rosendaal F.R., Koster T., Vandenbroucke J.P., and Reitsma P.H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 85 (1995) 1504-1508
    • (1995) Blood , vol.85 , pp. 1504-1508
    • Rosendaal, F.R.1    Koster, T.2    Vandenbroucke, J.P.3    Reitsma, P.H.4
  • 7
    • 0032520041 scopus 로고    scopus 로고
    • Factor V Cambridge. A new mutation (Arg306 to Thr) associated with resistance to activated protein C
    • Williamson D., Brown K., Luddington R., and Baglin C. Factor V Cambridge. A new mutation (Arg306 to Thr) associated with resistance to activated protein C. Blood 91 (1998) 1140
    • (1998) Blood , vol.91 , pp. 1140
    • Williamson, D.1    Brown, K.2    Luddington, R.3    Baglin, C.4
  • 8
    • 0032520034 scopus 로고    scopus 로고
    • A novel mutation of Arg306 of factor V gene in Hong Kong Chinese
    • Chan W.P., Lee C.K., Kwong Y.L., Lam C.K., and Liang R. A novel mutation of Arg306 of factor V gene in Hong Kong Chinese. Blood 91 (1998) 1135
    • (1998) Blood , vol.91 , pp. 1135
    • Chan, W.P.1    Lee, C.K.2    Kwong, Y.L.3    Lam, C.K.4    Liang, R.5
  • 9
    • 0030860494 scopus 로고    scopus 로고
    • A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype
    • Bernardi F., Faioni E.M., Castoldi E., Lunghi B., Castaman G., Sacchi E., Mannucci P.M., et al. A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype. Blood 90 (1997) 1552-1557
    • (1997) Blood , vol.90 , pp. 1552-1557
    • Bernardi, F.1    Faioni, E.M.2    Castoldi, E.3    Lunghi, B.4    Castaman, G.5    Sacchi, E.6    Mannucci, P.M.7
  • 12
  • 13
    • 0024365425 scopus 로고
    • Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits
    • Noe D.A., Murphy P.A., Bell W.R., and Siegel J.N. Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. Am J Physiol. 257 (1989) R49-56
    • (1989) Am J Physiol. , vol.257
    • Noe, D.A.1    Murphy, P.A.2    Bell, W.R.3    Siegel, J.N.4
  • 14
    • 0036908576 scopus 로고    scopus 로고
    • Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)
    • Tsai A.W., Cushman M., Rosamond W.D., Heckbert S.R., Tracy R.P., Aleksic N., and Folsom A.R. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 113 (2002) 636-642
    • (2002) Am J Med. , vol.113 , pp. 636-642
    • Tsai, A.W.1    Cushman, M.2    Rosamond, W.D.3    Heckbert, S.R.4    Tracy, R.P.5    Aleksic, N.6    Folsom, A.R.7
  • 16
    • 42749088081 scopus 로고    scopus 로고
    • Factor V Leiden: Is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?
    • Biswas A., Bajaj J., Ranjan R., Meena A., Akhter M.S., Yadav B.K., Sharma V., et al. Factor V Leiden: Is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?. Clin Chim Acta 392 (2008) 21-24
    • (2008) Clin Chim Acta , vol.392 , pp. 21-24
    • Biswas, A.1    Bajaj, J.2    Ranjan, R.3    Meena, A.4    Akhter, M.S.5    Yadav, B.K.6    Sharma, V.7
  • 17
    • 0035830874 scopus 로고    scopus 로고
    • Homocysteine inhibits inactivation of factor Va by activated protein C
    • Undas A., Williams E.B., Butenas S., Orfeo T., and Mann K.G. Homocysteine inhibits inactivation of factor Va by activated protein C. J Biol Chem 276 (2001) 4389-4397
    • (2001) J Biol Chem , vol.276 , pp. 4389-4397
    • Undas, A.1    Williams, E.B.2    Butenas, S.3    Orfeo, T.4    Mann, K.G.5
  • 18
    • 85047687532 scopus 로고    scopus 로고
    • Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden"
    • Graf L.L., Welsh C.H., Qamar Z., and Marlar R.A. Activated protein C resistance assay detects thrombotic risk factors other than factor V Leiden". Am J Clin Pathol 119 (2003) 52-60
    • (2003) Am J Clin Pathol , vol.119 , pp. 52-60
    • Graf, L.L.1    Welsh, C.H.2    Qamar, Z.3    Marlar, R.A.4
  • 19
    • 0037946750 scopus 로고    scopus 로고
    • "Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease"
    • Lecumberri R., Ceberio I., Montes R., López M.L., Alberca I., Rocha E., et al. "Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease". Haematologica 88 (2003) 236-237
    • (2003) Haematologica , vol.88 , pp. 236-237
    • Lecumberri, R.1    Ceberio, I.2    Montes, R.3    López, M.L.4    Alberca, I.5    Rocha, E.6
  • 20
    • 13244260855 scopus 로고    scopus 로고
    • Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke
    • Duran R., Biner B., Demir M., Celtik C., and Karasalihoǧlu S. Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke. Clin Appl Thromb Hemost 11 (2005) 83-88
    • (2005) Clin Appl Thromb Hemost , vol.11 , pp. 83-88
    • Duran, R.1    Biner, B.2    Demir, M.3    Celtik, C.4    Karasalihoǧlu, S.5
  • 21
    • 0033578475 scopus 로고    scopus 로고
    • Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators
    • Folsom A.R., Rosamond W.D., Shahar E., Cooper L.S., Aleksic N., Nieto F.J., Rasmussen M.L., et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100 (1999) 736-742
    • (1999) Circulation , vol.100 , pp. 736-742
    • Folsom, A.R.1    Rosamond, W.D.2    Shahar, E.3    Cooper, L.S.4    Aleksic, N.5    Nieto, F.J.6    Rasmussen, M.L.7
  • 22
    • 0033965871 scopus 로고    scopus 로고
    • Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response
    • O'Donnell J., Mumford A.D., Manning R.A., and Laffan M. Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 83 (2000) 10-13
    • (2000) Thromb Haemost , vol.83 , pp. 10-13
    • O'Donnell, J.1    Mumford, A.D.2    Manning, R.A.3    Laffan, M.4
  • 23
    • 0028793802 scopus 로고
    • Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity
    • Henkens C.M., Bom V.J., and van der Meer J. Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity. Thromb Haemost 74 (1995) 1198-1199
    • (1995) Thromb Haemost , vol.74 , pp. 1198-1199
    • Henkens, C.M.1    Bom, V.J.2    van der Meer, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.